普立沙福对淋巴瘤和多发性骨髓瘤患者干细胞动员的影响

IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL

Marmara Medical Journal Pub Date : 2023-01-31 DOI:10.5472/marumj.1244684

A. Uysal, M. Erkurt, Irfan Kuru, E. Kaya, İ. Berber, A. Sarici, S. Biçim, Ahmet Kaya, Emine Hidayet

{"title":"普立沙福对淋巴瘤和多发性骨髓瘤患者干细胞动员的影响","authors":"A. Uysal, M. Erkurt, Irfan Kuru, E. Kaya, İ. Berber, A. Sarici, S. Biçim, Ahmet Kaya, Emine Hidayet","doi":"10.5472/marumj.1244684","DOIUrl":null,"url":null,"abstract":"ABSTRACT \nObjective: The aim of this study is to investigate the effect of the preemptive use of plerixafor in patients with lymphoma and multiple \nmyeloma which was administered as a preemptive single dose to the patients who were determined to have a CD34+ cell count of","PeriodicalId":43341,"journal":{"name":"Marmara Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2023-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The effect of preemptive use of plerixafor on stem cell mobilization in patients with lymphoma and multiple myeloma\",\"authors\":\"A. Uysal, M. Erkurt, Irfan Kuru, E. Kaya, İ. Berber, A. Sarici, S. Biçim, Ahmet Kaya, Emine Hidayet\",\"doi\":\"10.5472/marumj.1244684\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"ABSTRACT \\nObjective: The aim of this study is to investigate the effect of the preemptive use of plerixafor in patients with lymphoma and multiple \\nmyeloma which was administered as a preemptive single dose to the patients who were determined to have a CD34+ cell count of\",\"PeriodicalId\":43341,\"journal\":{\"name\":\"Marmara Medical Journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2023-01-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Marmara Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5472/marumj.1244684\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Marmara Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5472/marumj.1244684","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

摘要

【摘要】目的:本研究的目的是探讨在淋巴瘤和多发性骨髓瘤患者中预先使用普利沙福的效果，该患者被确定为CD34+细胞计数

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The effect of preemptive use of plerixafor on stem cell mobilization in patients with lymphoma and multiple myeloma

ABSTRACT Objective: The aim of this study is to investigate the effect of the preemptive use of plerixafor in patients with lymphoma and multiple myeloma which was administered as a preemptive single dose to the patients who were determined to have a CD34+ cell count of

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Marmara Medical Journal MEDICINE, GENERAL & INTERNAL-

CiteScore

0.30

自引率

0.00%

发文量

期刊介绍： Marmara Medical Journal, Marmara Üniversitesi Tıp Fakültesi tarafından yılda üç kere yayımlanan multidisipliner bir dergidir. Bu dergide tıbbın tüm alanlarına ait orijinal araştırma makaleleri, olgu sunumları ve derlemeler İngilizce veya Türkçe olarak yer alır.